A team of scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC), working in collaboration with international partners, has designed a strategy for preventing the cardiotoxic ...

CardioOncology, shows that administration of the SGLT2 inhibitor empagliflozin to pigs receiving anthracyclines preserves ...

Patients who received anthracyclines in addition to taxane-based chemotherapy experienced improved survival. Patients with a higher recurrence score more likely benefited from anthracyclines.

A non-exhaustive list of examples of drugs that combine anticancer and immunostimulatory effects includes: imatinib mesylate, cyclophosphamide, anthracyclines and 5-fluorouracil. Imatinib mesylate ...

"Anthracyclines should be considered in patients with high genomic-risk, hormone receptor-positive [HR+], node-negative disease," she concluded. The study added to an ongoing debate about the role ...

As their use increased, however, it became evident that anthracyclines carry a risk of cardiotoxicity, which in some cases could be irreversible, as well as a risk of secondary leukemia.